FCGR3A and rheumatoid arthritis: CD14+ and CD16+ cells are characterized by the increased expression of pro-inflammatory markers and the production of pro-inflammatory cytokines, as well as the ability to stimulate Th17 responses, all of which contribute to the pathogenesis of autoimmune inflammation in RA [31].